Last reviewed · How we verify

Non-Vitamin K Oral Anticoagulant

Boston Scientific Corporation · Phase 1 active Small molecule

Non-Vitamin K Oral Anticoagulant is a Small molecule drug developed by Boston Scientific Corporation. It is currently in Phase 1 development. Also known as: NOAC.

At a glance

Generic nameNon-Vitamin K Oral Anticoagulant
Also known asNOAC
SponsorBoston Scientific Corporation
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Non-Vitamin K Oral Anticoagulant

What is Non-Vitamin K Oral Anticoagulant?

Non-Vitamin K Oral Anticoagulant is a Small molecule drug developed by Boston Scientific Corporation.

Who makes Non-Vitamin K Oral Anticoagulant?

Non-Vitamin K Oral Anticoagulant is developed by Boston Scientific Corporation (see full Boston Scientific Corporation pipeline at /company/boston-scientific-corporation).

Is Non-Vitamin K Oral Anticoagulant also known as anything else?

Non-Vitamin K Oral Anticoagulant is also known as NOAC.

What development phase is Non-Vitamin K Oral Anticoagulant in?

Non-Vitamin K Oral Anticoagulant is in Phase 1.

Related